Announcing the Theme for the 5th National Summit on Smokeless and Spit Tobacco, and the keynote speaker.
The theme for the summit is: "New Products, New Users and a New Generation of Advocacy." We are also pleased to announce that we have confirmed the summit keynote speaker: Jack Henningfield.
Jack E. Henningfield, Ph.D., is Adjunct Professor of Behavioral Biology, Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine, and Vice President for Research and Health Policy at Pinney Associates. Pinney Associates is a consulting firm in Bethesda, Maryland that specializes in science policy and regulatory issues concerning public health, medications development, and behavior-focused disease management, including the development of addiction treatment for commercial and not-for-profit clients. Dr. Henningfield was selected to be the new Director of The Robert Wood Johnson Foundation’s Innovators Combating Substance Abuse Awards Program at the Johns Hopkins University School of Medicine in December 2002.
Dr Henningfield has investigated addictive drugs, including alcohol, cocaine, marijuana, morphine, and nicotine, as well as medications for treating addiction and other disorders. Much of his research was conducted at the National Institute on Drug Abuse where he was a principal investigator and directed several laboratories dedicated to the study of addictive drugs and addiction treatment from 1980 until 1996. He has also taught and conducted research at the Johns Hopkins University School of Medicine since 1978. One of Dr. Henningfield’s major areas of research has been on tobacco and nicotine. His research has contributed to the understanding of nicotine as an addictive drug, and has advanced the treatment of tobacco dependence and withdrawal. He continues his research and public health efforts by working with non-governmental organizations on public health policy, academic institutions in their research and training efforts, and pharmaceutical companies in their medications development and evaluation efforts. Dr. Henningfield continues to serve as advisor and consultant to various departments of the U.S. Federal Government, the World Health Organization, and other organizations that address issues of tobacco, drug addiction and health.
Dr. Henningfield has published more than 300 journal articles and book chapters, several books and monographs, and contributed to numerous reports of the U.S. Surgeon General, the National Academy of Sciences, and the World Health Organization. Dr. Henningfield is past President of the Society for Research on Nicotine and Tobacco, a charter fellow of the College on Problems of Drug Dependence, and Senior Advisor to The Robert Wood Johnson Foundation’s Tobacco Etiology Research Network that is studying the science base for preventing tobacco addiction. He has received awards from the U.S. Public Health Service, the World Health Organization, and international organizations dedicated to public health and addiction control for his research and efforts to increase the participation of ethnic minorities in drug addiction science. Dr. Henningfield is the recipient of The Robert Wood Johnson Foundation’s Innovators Combating Substance Abuse Award in 2000, which he used to support efforts to assess and disseminate the science foundation for tobacco control policy.
Dr. Henningfield is a summa cum laude graduate of the University of Minnesota (B.A., 1974), where he also obtained his Ph.D. in psychology, with a supporting program in psychopharmacology (1977). Additional training included fellowships from the National Council on Alcoholism and the National Institute on Drug Abuse.
Dr. Henningfield consults to private and nonprofit organizations on addiction control, risk management and other issues at the intersection of science, health and policy, through Pinney Associates (see www.pinneyassociates.com).